Supplemental Material, 820050_Appendix_1_and_Appendix_2 for Determinants of Generic Drug Substitution in the United States by Jodi B. Segal, Oluwadamilola Onasanya, Matthew Daubresse, Chia-Ying Lee, Mischka Moechtar, Xia Pu, Sarah K. Dutcher, and Robert J. Romanelli in Therapeutic Innovation & Regulatory Science</p
Supplemental material, Supplemental_Appendix_A for Quantitative Synthesis of Research Evidence: Mult...
Supplemental Material, 838468_Appendix for Notable Differences in Drug Lag Between Korea and Japan o...
<p>Supplemental material, Appendix 1 for Identifying positive deviants in healthcare quality and saf...
Supplemental Material, 839009_Appendix for Estimating the Impact of Food and Drug Administration’s U...
Supplemental Material, 812058_web_appendix for Clinical Development of Biologics Approved by the US ...
<p>Supplemental Material, Appendix_A_TIRS784910 for Validation Master Plans: Progress of Implementat...
<p>Supplementary Material - Use_of_Proprietary_Names_by_Prescribers_for_Generic_Products_Supplementa...
Supplemental Material, 793375_APPENDIX_A for Comparison of Postdoctoral Pharmacy Training Programs: ...
Supplemental material, Appendix_A_MCRR for Interventions to Decrease Use in Prehospital and Emergenc...
Supplemental material, 820429_supplemental_appendix for An Exploratory Analysis of Quality Indicator...
<p>Supplemental Material, Appendix_1 for Reported Adverse Drug Reactions During the Use of Corticost...
<p>Supplemental Material, Appendix_2 for Reported Adverse Drug Reactions During the Use of Corticost...
Supplemental Material, Web_Appendix for An Investigation of Nonbeneficiary Reactions to Discretionar...
<p>Supplemental Material, Appendix_4 for Reported Adverse Drug Reactions During the Use of Corticost...
<p>Supplemental Material, Appendix_3 for Reported Adverse Drug Reactions During the Use of Corticost...
Supplemental material, Supplemental_Appendix_A for Quantitative Synthesis of Research Evidence: Mult...
Supplemental Material, 838468_Appendix for Notable Differences in Drug Lag Between Korea and Japan o...
<p>Supplemental material, Appendix 1 for Identifying positive deviants in healthcare quality and saf...
Supplemental Material, 839009_Appendix for Estimating the Impact of Food and Drug Administration’s U...
Supplemental Material, 812058_web_appendix for Clinical Development of Biologics Approved by the US ...
<p>Supplemental Material, Appendix_A_TIRS784910 for Validation Master Plans: Progress of Implementat...
<p>Supplementary Material - Use_of_Proprietary_Names_by_Prescribers_for_Generic_Products_Supplementa...
Supplemental Material, 793375_APPENDIX_A for Comparison of Postdoctoral Pharmacy Training Programs: ...
Supplemental material, Appendix_A_MCRR for Interventions to Decrease Use in Prehospital and Emergenc...
Supplemental material, 820429_supplemental_appendix for An Exploratory Analysis of Quality Indicator...
<p>Supplemental Material, Appendix_1 for Reported Adverse Drug Reactions During the Use of Corticost...
<p>Supplemental Material, Appendix_2 for Reported Adverse Drug Reactions During the Use of Corticost...
Supplemental Material, Web_Appendix for An Investigation of Nonbeneficiary Reactions to Discretionar...
<p>Supplemental Material, Appendix_4 for Reported Adverse Drug Reactions During the Use of Corticost...
<p>Supplemental Material, Appendix_3 for Reported Adverse Drug Reactions During the Use of Corticost...
Supplemental material, Supplemental_Appendix_A for Quantitative Synthesis of Research Evidence: Mult...
Supplemental Material, 838468_Appendix for Notable Differences in Drug Lag Between Korea and Japan o...
<p>Supplemental material, Appendix 1 for Identifying positive deviants in healthcare quality and saf...